Chris Brough

1.5k total citations · 1 hit paper
16 papers, 1.3k citations indexed

About

Chris Brough is a scholar working on Pharmaceutical Science, Materials Chemistry and Molecular Biology. According to data from OpenAlex, Chris Brough has authored 16 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmaceutical Science, 8 papers in Materials Chemistry and 3 papers in Molecular Biology. Recurrent topics in Chris Brough's work include Drug Solubulity and Delivery Systems (14 papers), Crystallization and Solubility Studies (8 papers) and Advanced Drug Delivery Systems (6 papers). Chris Brough is often cited by papers focused on Drug Solubulity and Delivery Systems (14 papers), Crystallization and Solubility Studies (8 papers) and Advanced Drug Delivery Systems (6 papers). Chris Brough collaborates with scholars based in United States, Germany and Switzerland. Chris Brough's co-authors include Robert O. Williams, Scott V. Jermain, Dave A. Miller, James W. McGinity, Justin R. Hughey, James C. DiNunzio, Justin M. Keen, Dieter Lubda, Leena Kumari Prasad and Justin S. LaFountaine and has published in prestigious journals such as International Journal of Pharmaceutics, Journal of Pharmaceutical Sciences and European Journal of Pharmaceutics and Biopharmaceutics.

In The Last Decade

Chris Brough

15 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery – An update

2017 339 citations Scott V. Jermain, Chris Brough et al. International Journal of Pharmaceutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chris Brough United States	15	994	445	243	189	166	16	1.3k
James C. DiNunzio United States	20	919 0.9×	419 0.9×	244 1.0×	167 0.9×	165 1.0×	32	1.2k
Aditya Mohan Kaushal India	17	850 0.9×	432 1.0×	157 0.6×	143 0.8×	186 1.1×	25	1.3k
Norbert Rasenack Germany	12	801 0.8×	501 1.1×	178 0.7×	213 1.1×	174 1.0×	15	1.3k
Shrawan Baghel Ireland	5	757 0.8×	428 1.0×	157 0.6×	200 1.1×	97 0.6×	6	1.0k
Karl Kolter Germany	19	883 0.9×	300 0.7×	218 0.9×	152 0.8×	118 0.7×	40	1.3k
Cristina Cavallari Italy	21	879 0.9×	297 0.7×	169 0.7×	169 0.9×	207 1.2×	40	1.2k
Sandrien Janssens Belgium	11	1.0k 1.0×	602 1.4×	205 0.8×	287 1.5×	111 0.7×	13	1.3k
Matthias Manne Knopp Denmark	18	783 0.8×	484 1.1×	173 0.7×	235 1.2×	83 0.5×	43	1.1k
Yatindra M. Joshi United States	16	879 0.9×	432 1.0×	217 0.9×	249 1.3×	137 0.8×	18	1.2k
Yiwei Tian United Kingdom	19	676 0.7×	536 1.2×	211 0.9×	237 1.3×	84 0.5×	35	1.1k

Countries citing papers authored by Chris Brough

Since Specialization

Citations

This map shows the geographic impact of Chris Brough's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Brough with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Brough more than expected).

Fields of papers citing papers by Chris Brough

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Brough. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Brough. The network helps show where Chris Brough may publish in the future.

Co-authorship network of co-authors of Chris Brough

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Brough. A scholar is included among the top collaborators of Chris Brough based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Brough. Chris Brough is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Blake, Denise, et al.. (2022). Accessing needle exchange services in disasters for remote areas of Aotearoa New Zealand. Harm Reduction Journal. 19(1). 145–145.

Jermain, Scott V., Chris Brough, & Robert O. Williams. (2017). Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery – An update. International Journal of Pharmaceutics. 535(1-2). 379–392. 339 indexed citations breakdown →

Brough, Chris, et al.. (2016). Use of Polyvinyl Alcohol as a Solubility Enhancing Polymer for Poorly Water-Soluble Drug Delivery (Part 2). AAPS PharmSciTech. 17(1). 180–190. 29 indexed citations

LaFountaine, Justin S., Scott V. Jermain, Leena Kumari Prasad, et al.. (2016). Enabling thermal processing of ritonavir–polyvinyl alcohol amorphous solid dispersions by KinetiSol® Dispersing. European Journal of Pharmaceutics and Biopharmaceutics. 101. 72–81. 42 indexed citations

Brough, Chris, Dave A. Miller, Justin M. Keen, et al.. (2015). Use of Polyvinyl Alcohol as a Solubility-Enhancing Polymer for Poorly Water Soluble Drug Delivery (Part 1). AAPS PharmSciTech. 17(1). 167–179. 77 indexed citations

LaFountaine, Justin S., Leena Kumari Prasad, Chris Brough, et al.. (2015). Thermal Processing of PVP- and HPMC-Based Amorphous Solid Dispersions. AAPS PharmSciTech. 17(1). 120–132. 56 indexed citations

Miller, Dave A., et al.. (2015). Bioavailability enhancement of a BCS IV compound via an amorphous combination product containing ritonavir. Journal of Pharmacy and Pharmacology. 68(5). 678–691. 17 indexed citations

Brough, Chris, Dave A. Miller, K.P. O’Donnell, et al.. (2013). Preparation of amorphous solid dispersions by rotary evaporation and KinetiSol Dispersing: approaches to enhance solubility of a poorly water-soluble gum extract. Drug Development and Industrial Pharmacy. 41(3). 382–397. 30 indexed citations

Brough, Chris & Robert O. Williams. (2013). Amorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug delivery. International Journal of Pharmaceutics. 453(1). 157–166. 242 indexed citations

10.

Hughey, Justin R., Justin M. Keen, Dave A. Miller, Chris Brough, & James W. McGinity. (2012). Preparation and characterization of fusion processed solid dispersions containing a viscous thermally labile polymeric carrier. International Journal of Pharmaceutics. 438(1-2). 11–19. 35 indexed citations

11.

Hughey, Justin R., et al.. (2011). Thermal processing of a poorly water-soluble drug substance exhibiting a high melting point: The utility of KinetiSol® Dispersing. International Journal of Pharmaceutics. 419(1-2). 222–230. 61 indexed citations

12.

DiNunzio, James C., Chris Brough, Dave A. Miller, Robert O. Williams, & James W. McGinity. (2010). Applications of KinetiSol® Dispersing for the production of plasticizer free amorphous solid dispersions. European Journal of Pharmaceutical Sciences. 40(3). 179–187. 51 indexed citations

13.

Hughey, Justin R., James C. DiNunzio, Chris Brough, et al.. (2010). Dissolution Enhancement of a Drug Exhibiting Thermal and Acidic Decomposition Characteristics by Fusion Processing: A Comparative Study of Hot Melt Extrusion and KinetiSol® Dispersing. AAPS PharmSciTech. 11(2). 760–774. 57 indexed citations

14.

DiNunzio, James C., Justin R. Hughey, Chris Brough, et al.. (2010). Production of advanced solid dispersions for enhanced bioavailability of itraconazole using KinetiSol® Dispersing. Drug Development and Industrial Pharmacy. 36(9). 1064–1078. 54 indexed citations

15.

DiNunzio, James C., Chris Brough, Justin R. Hughey, et al.. (2009). Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and Kinetisol® dispersing. European Journal of Pharmaceutics and Biopharmaceutics. 74(2). 340–351. 108 indexed citations

16.

DiNunzio, James C., Chris Brough, Dave A. Miller, Robert O. Williams, & James W. McGinity. (2009). Fusion processing of itraconazole solid dispersions by kinetisol® dispersing: A comparative study to hot melt extrusion. Journal of Pharmaceutical Sciences. 99(3). 1239–1253. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact